RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O
     

-A +A

Syndrome de Turcot confirmé par biologie moléculaire

JEANNIN S; LEBRUN C; VAN DEN BOS F; OLSCHWANG S; BOURG V; FRENAY M
REV NEUROL (Paris) , 2006, vol. 162, n° 6-7, p. 741-746
Doc n°: 126081
Localisation : Documentation IRR
Descripteurs : AD12 - PATHOLOGIQUE - ETUDES GENERALES - SEMIOLOGIE ET SYNDROMES CENTRAUX

Turcot's syndrome is characterized clinically by the concurrence of a primary brain tumor and a familial adenomatous polyposis or a hereditary nonpolyposis colorectal cancer. We report a case of a 45-year-old woman who underwent in 1995 neuro-oncological treatment for an anaplastic astrocytoma (grade III according to the World Health Organization classification). Treatment included complete surgery, radiotherapy, a first-line nitrosourea-based chemotherapy regimen and a second-line platinium salt-based regimen. It was then noted that the patient's brother had colorectal cancer.
A genetic study detected a germ-line mutation on the hMSH2 gene specific of HNPCC syndrome (Human Non Polyposis Colorectal Cancer). Colonoscopy was normal. Eight years after the diagnosis, the patient developed a gliomatosis cerebri and died. CONCLUSION: Relevant personal and familial history can provide the clue to the diagnosis of Turcot's syndrome. Molecular diagnosis may contribute to appropriate care of affected patients.

Langue : FRANCAIS

Mes paniers

4

Gerer mes paniers

0